Ann: Mesoblast Type A Meeting with FDA, page-472

A blind man can see that every single post you make here is not impartial and full of rhetoric that favour's the bearish with a complete disregard for anything positive - especially when it comes to the science.

I leave the ... er... science to others to argue over.

In my mind evidence of The Science^TM that will be above dissent will occur when it brings the company to a state of self-sustaining commercialisation.

At that point my bearish-favouring rhetoric [*] will change, and I will then be able to perform an assessment of the intrinsic value of the business, per my investment process which is unwavering.

As for my "defence of whytee", had you been paying attention you would have seen that I was merely responding to another poster who made the association between whytee and madamswer. I don't know whytee from a brick in the wall; the only thing I observe about him/her is that his/her cautious stance on MSB has been proven correct. So there's that.

[*] bearishness which, self-evidently, has served me well by me not being a shareholder all the while the stock has fallen over a period of many years to its current all-time low.